Lung cancer and mesothelioma

PheWeb

LUNG_CANCER_MESOT

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 C34, C38.4&

Hospital discharge: ICD-9 162|163

Hospital discharge: ICD-8 162|16301

Cause of death: ICD-10 C34, C38.4&

Cause of death: ICD-9 162|163

Cause of death: ICD-8 162|16301

Cancer registry: Topography ICD-O-3 C34|C384

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

5328

LUNG_CANCER_MESOT

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Lung cancer and mesothelioma based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	5157	1331	3826
Unadjusted prevalence (%)	1.67	0.77	2.83
Mean age at first event (years)	69.95	66.81	71.05

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.28	25.84 [21.58, 30.94]	<1e-100	2732
15 years	0.01	2.20 [1.78, 2.71]	1.9e-13	166
5 years	0.02	16.90 [14.41, 19.81]	<1e-100	731
1 year	0.02	91.86 [80.17, 105.27]	<1e-100	1826

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: LUNG_CANCER_MESOT – Lung cancer and mesothelioma
GWS hits:

Survival analyses between endpoints

↥

Plot

before Lung cancer and mesothelioma
after Lung cancer and mesothelioma

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Lung cancer and mesothelioma

↥